Adam S. Mostafa, Chief Financial Officer at X4 Pharmaceuticals, Inc (XFOR), sold 2,641 shares at $1.89 ($5K) on 2023-06-30, disclosed to the SEC on 2023-07-05.
Scheduled sale ($5k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| XFOR | SELL | 2024-03-11 | $46K | — | Filing → |
| XFOR | SELL | 2024-02-12 | $28K | — | Filing → |
| XFOR | SELL | 2023-11-03 | $337K | — | Filing → |